The CDC just released new recommendations for the shot in June 2024, focusing on folks that are 60 or older, who are ...
In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV ...
Overall, 55.8% of infants were protected by either maternal RSV vaccination, nirsevimab, or both; 14.2% of infants were ...
Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
The 2024-25 respiratory season is underway and for the first time, New Brunswick will offer some seniors immunization against ...
A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of RSV in 2021, according to a ...
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
Poynter has partnered with the Risk Less. Do More. campaign to host a webinar, articles to better inform journalists.
The American Lung Association is launching a new campaign aimed at boosting RSV vaccine rates. Health experts say nearly 80,000 children up to five years old are hospitalized each year with RSV.